Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researchers discover key gene essential for survival of leukemia stem cells

Researchers discover key gene essential for survival of leukemia stem cells

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

KinaRx receives SBIR grant to speed up clinical trials for AML and other diseases

Developing an international consortium to improve clinical decision-making in Hodgkin lymphoma

Developing an international consortium to improve clinical decision-making in Hodgkin lymphoma

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

Scientists identify factors influencing outcomes in kidney cancer patients treated with immunotherapy

Toshiba and Shinshu University jointly develop a 'tumor-tropic liposome technology' for gene therapy

Toshiba and Shinshu University jointly develop a 'tumor-tropic liposome technology' for gene therapy

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

Study analyzes cancer diagnosis in children with birth defects

Study analyzes cancer diagnosis in children with birth defects

Cancer drug nilotinib found to be safe and well-tolerated in Alzheimer's disease clinical trial

Cancer drug nilotinib found to be safe and well-tolerated in Alzheimer's disease clinical trial

Combination therapy does not show superior efficacy in newly diagnosed myeloma

Combination therapy does not show superior efficacy in newly diagnosed myeloma

Combination therapy found to be effective against IDH1-mutated acute myeloid leukemia

Combination therapy found to be effective against IDH1-mutated acute myeloid leukemia

Transgenic mouse model of HLH may play key role in saving lives during COVID-19

Transgenic mouse model of HLH may play key role in saving lives during COVID-19

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Understanding why pancreatic ductal adenocarcinoma is so aggressive

Understanding why pancreatic ductal adenocarcinoma is so aggressive

A new tool to study and map the intricacies of intercellular signaling

A new tool to study and map the intricacies of intercellular signaling

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Mouse model helps track organism’s development from embryonic stage to adulthood

Mouse model helps track organism’s development from embryonic stage to adulthood

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

Harnessing the formation of natural killer–tumor cell immunological synapse to treat solid cancers

Harnessing the formation of natural killer–tumor cell immunological synapse to treat solid cancers

Scientists develop new method to synthesize cotylenin A

Scientists develop new method to synthesize cotylenin A

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia